Orgenesis Inc. Investing cash flow

Investing cash flow of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending March 31, 2022 was $-3.23 Million (a -46.07% decrease compared to previous quarter)
  • Year-over-year quarterly Investing cash flow increased by 215.35%
  • Annual Investing cash flow for 2021 was $-12.4 Million (a -112.43% decrease from previous year)
  • Annual Investing cash flow for 2020 was $99.6 Million (a -17336.68% decrease from previous year)
  • Annual Investing cash flow for 2019 was $-578 Thousand (a -107.42% decrease from previous year)
  • Twelve month Investing cash flow ending March 31, 2022 was $-15.1 Million (a 21.7% increase compared to previous quarter)
  • Twelve month trailing Investing cash flow decreased by -1281.11% year-over-year
Trailing Investing cash flow for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-15.1 Million $-12.4 Million $-4.66 Million $1.28 Million
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of Orgenesis Inc.

Most recent Investing cash flowof ORGS including historical data for past 10 years.

Interactive Chart of Investing cash flow of Orgenesis Inc.

Orgenesis Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-3.23
2021 $-5.98 $-4.84 $-1.02 $-0.54 $-12.38
2020 $1.75 $1.09 $-0.27 $103.05 $99.63
2019 $-6.51 $-3.32 $-1.58 $-2.36 $-0.58
2018 $-2.64 $-1.24 $-2.08 $-0.9 $7.79
2017 $-0.54 $-0.49 $-0.41 $-0.41 $-1.06
2016 $-0.33 $-0.34 $-0.7 $-0.71 $-1.54
2015 $-0.93 $-0.93
2014 $0.0 $0.0
2013 $0.0 $-0.01
2012 $0.0 $0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology